| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |